Parazelsus Competitors and Similar CompaniesClear all

Parazelsus's competitors and similar companies include UDG Healthcare, Novolog, The BirgiMefar Group and Gerresheimer.

	Parazelsus Parazelsus is a company that operates as pharma and medical distributor.	UDG Healthcare UDG Healthcare is a company providing services to the healthcare and life sciences industries.	Novolog Novolog (created by a merger of Novolog and Pharm Up) is a health logistics company.	The BirgiMefar Group The BirgiMefar Group is a manufacturer of medical products.	Gerresheimer Gerresheimer is a company that manufactures and sells packaging products and drug delivery systems.
Founding Date	Founding Date 2007	Founding Date 1948	Founding Date 1966	Founding Date 1963	Founding Date 1864
Type	Type Private	Type Subsidiary	Type Public	Type Private	Type Public
Tags	Tags Healthcare distribution logistics medical devices packaging pharma	Tags Healthcare medical devices packaging pharma	Tags Healthcare logistics medical devices pharma	Tags Healthcare medical devices packaging pharma	Tags Healthcare medical devices paper and packaging pharma plastic
Locations	Locations Karachi, PK HQ Kabol, AF Dhaka, BD Thane, IN	Locations Dublin, IE HQ	Locations Modi'in-Maccabim-Re'ut, IL HQ	Locations TR HQ	Locations Düsseldorf, DE HQ Momignies, BE Anapolis, BR Sao Paulo, BR Sao Paulo, BR Chang Zhou Shi, CN Danyang, CN see more
Employees	Employees 472% increase	Employees 2,5121% increase	Employees 936	Employees 430	Employees 13,632
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1.3b (FY, 2020)	Revenue (est.) ₪1.8b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €2b (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods $799.2m (FY, 2020)	Cost of goods ₪1.4b (FY, 2025)	Cost of goods N/A	Cost of goods €1.2b (FY, 2024)
Gross profit	Gross profit N/A	Gross profit $485.2m (FY, 2020)	Gross profit ₪388.4m (FY, 2025)	Gross profit N/A	Gross profit €870.9m (FY, 2024)
Net income	Net income N/A	Net income $92.8m (FY, 2020)	Net income ₪4.5m (FY, 2025)	Net income N/A	Net income €112.3m (FY, 2024)